4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-129154
Options or other derivatives
- See Remarks acquired 219,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Simms Christopher Paul See Remarks | 2026-03-25 | Grant or award · Stock Option (Right to Buy) | +219,000 | 219,000 | D: show line 1 in the form |
Loading xslF345X06/ownership.xml…